Global Subcutaneous Immunoglobulin Market Size, Share, Forecast Report, 2020-2027

The global Subcutaneous Immunoglobulin market garnered revenue around USD 4.1 Million in 2019 and projected to reach USD 12.3 Billion in 2027, with at a compound annual growth rate (CAGR) 13.2% throughout the estimate period from 2020 to 2027.

Subcutaneous Immunoglobulin is used for treatment of primary immunodeficiency diseases, secondary immunodeficiency diseases, and others. Subcutaneous immunoglobulins are efficacious, well-tolerated, have a favorable safety profile, and are suitable for all patients where clinically appropriate. Subcutaneous immunoglobulins are preferred to intravenous immunoglobulins, as venous access is not required and the need for premedication with corticosteroids and anti-histamines is reduced.

North America dominated the global subcutaneous immunoglobulins market in 2018 and the trend is anticipated to continue during the forecast period. Highly structured health care industry, increased usage of subcutaneous immunoglobulins for treatment of various autoimmune disorders, and new product launch are expected to drive the market in North America. Asia Pacific is likely to be a highly lucrative market for subcutaneous immunoglobulin and it is expected to expand at a high CAGR during the forecast period

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Subcutaneous Immunoglobulin market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Subcutaneous Immunoglobulin market growth.

The global Subcutaneous Immunoglobulin market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

 the global market include Biotest AG, CSL Limited, Grifols, S.A.  Kedrion S.p.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., LFB S.A. and other prominent players.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

• Global Subcutaneous Immunoglobulin Market, by Application
  • Primary Immunodeficiency Diseases
  • Secondary Immunodeficiency Diseases
  • Others
• Global Subcutaneous Immunoglobulin Market, by End-user
  • Hospital
  • Clinic
  • Home Care Setting

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA